Literature DB >> 29849206

Controversies in dose-escalation for locally advanced non-small cell lung cancer and the role of proton beam therapy.

Vivek Verma1, Joe Y Chang2.   

Abstract

Entities:  

Year:  2018        PMID： 29849206      PMCID： PMC5949409          DOI： 10.21037/jtd.2018.03.155

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  10 in total

1.  Bayesian Adaptive Randomization Trial of Passive Scattering Proton Therapy and Intensity-Modulated Photon Radiotherapy for Locally Advanced Non-Small-Cell Lung Cancer.

Authors:  Zhongxing Liao; J Jack Lee; Ritsuko Komaki; Daniel R Gomez; Michael S O'Reilly; Frank V Fossella; George R Blumenschein; John V Heymach; Ara A Vaporciyan; Stephen G Swisher; Pamela K Allen; Noah Chan Choi; Thomas F DeLaney; Stephen M Hahn; James D Cox; Charles S Lu; Radhe Mohan
Journal:  J Clin Oncol       Date:  2018-01-02       Impact factor: 44.544

Review 2.  Consensus Statement on Proton Therapy in Early-Stage and Locally Advanced Non-Small Cell Lung Cancer.

Authors:  Joe Y Chang; Salma K Jabbour; Dirk De Ruysscher; Steven E Schild; Charles B Simone; Ramesh Rengan; Steven Feigenberg; Atif J Khan; Noah C Choi; Jeffrey D Bradley; Xiaorong R Zhu; Antony J Lomax; Bradford S Hoppe
Journal:  Int J Radiat Oncol Biol Phys       Date:  2016-01-23       Impact factor: 7.038

Review 3.  Consensus Guidelines for Implementing Pencil-Beam Scanning Proton Therapy for Thoracic Malignancies on Behalf of the PTCOG Thoracic and Lymphoma Subcommittee.

Authors:  Joe Y Chang; Xiaodong Zhang; Antje Knopf; Heng Li; Shinichiro Mori; Lei Dong; Hsiao-Ming Lu; Wei Liu; Shahed N Badiyan; Stephen Both; Arturs Meijers; Liyong Lin; Stella Flampouri; Zuofeng Li; Kikuo Umegaki; Charles B Simone; Xiaorong R Zhu
Journal:  Int J Radiat Oncol Biol Phys       Date:  2017-05-19       Impact factor: 7.038

4.  Higher biologically effective dose of radiotherapy is associated with improved outcomes for locally advanced non-small cell lung carcinoma treated with chemoradiation: an analysis of the Radiation Therapy Oncology Group.

Authors:  Mitchell Machtay; Kyounghwa Bae; Benjamin Movsas; Rebecca Paulus; Elizabeth M Gore; Ritsuko Komaki; Kathy Albain; William T Sause; Walter J Curran
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-10-25       Impact factor: 7.038

5.  Impact of Intensity-Modulated Radiation Therapy Technique for Locally Advanced Non-Small-Cell Lung Cancer: A Secondary Analysis of the NRG Oncology RTOG 0617 Randomized Clinical Trial.

Authors:  Stephen G Chun; Chen Hu; Hak Choy; Ritsuko U Komaki; Robert D Timmerman; Steven E Schild; Jeffrey A Bogart; Michael C Dobelbower; Walter Bosch; James M Galvin; Vivek S Kavadi; Samir Narayan; Puneeth Iyengar; Clifford G Robinson; Raymond B Wynn; Adam Raben; Mark E Augspurger; Robert M MacRae; Rebecca Paulus; Jeffrey D Bradley
Journal:  J Clin Oncol       Date:  2016-10-31       Impact factor: 44.544

6.  Radiation Treatment Time and Overall Survival in Locally Advanced Non-small Cell Lung Cancer.

Authors:  Matthew T McMillan; Eric Ojerholm; Vivek Verma; Kristin A Higgins; Sunil Singhal; Jarrod D Predina; Abigail T Berman; Surbhi Grover; Cliff G Robinson; Charles B Simone
Journal:  Int J Radiat Oncol Biol Phys       Date:  2017-04-11       Impact factor: 7.038

7.  Proton Beam Radiotherapy and Concurrent Chemotherapy for Unresectable Stage III Non-Small Cell Lung Cancer: Final Results of a Phase 2 Study.

Authors:  Joe Y Chang; Vivek Verma; Ming Li; Wencheng Zhang; Ritsuko Komaki; Charles Lu; Pamela K Allen; Zhongxing Liao; James Welsh; Steven H Lin; Daniel Gomez; Melenda Jeter; Michael O'Reilly; Ronald X Zhu; Xiaodong Zhang; Heng Li; Radhe Mohan; John V Heymach; Ara A Vaporciyan; Stephen Hahn; James D Cox
Journal:  JAMA Oncol       Date:  2017-08-10       Impact factor: 31.777

8.  Cost-comparativeness of proton versus photon therapy.

Authors:  Vivek Verma; Chirag Shah; Jean-Claude M Rwigema; Timothy Solberg; Xiaofeng Zhu; Charles B Simone
Journal:  Chin Clin Oncol       Date:  2016-07-27

9.  Durvalumab after Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer.

Authors:  Scott J Antonia; Augusto Villegas; Davey Daniel; David Vicente; Shuji Murakami; Rina Hui; Takashi Yokoi; Alberto Chiappori; Ki H Lee; Maike de Wit; Byoung C Cho; Maryam Bourhaba; Xavier Quantin; Takaaki Tokito; Tarek Mekhail; David Planchard; Young-Chul Kim; Christos S Karapetis; Sandrine Hiret; Gyula Ostoros; Kaoru Kubota; Jhanelle E Gray; Luis Paz-Ares; Javier de Castro Carpeño; Catherine Wadsworth; Giovanni Melillo; Haiyi Jiang; Yifan Huang; Phillip A Dennis; Mustafa Özgüroğlu
Journal:  N Engl J Med       Date:  2017-09-08       Impact factor: 91.245

Review 10.  A systematic review of the cost and cost-effectiveness studies of proton radiotherapy.

Authors:  Vivek Verma; Mark V Mishra; Minesh P Mehta
Journal:  Cancer       Date:  2016-02-01       Impact factor: 6.860
  10 in total
  2 in total

Review 1.  Proton therapy for non-small cell lung cancer: the road ahead.

Authors:  Eric D Brooks; Matthew S Ning; Vivek Verma; X Ronald Zhu; Joe Y Chang
Journal:  Transl Lung Cancer Res       Date:  2019-09

2.  Clinical Outcomes After Proton Beam Therapy for Locally Advanced Non-Small Cell Lung Cancer: Analysis of a Multi-institutional Prospective Registry.

Authors:  Aurélien Jongen; Florian Charlier; Kelsey Baker; John Chang; William Hartsell; George Laramore; Pranshu Mohindra; Luigi Moretti; Mary Redman; Lane Rosen; Henry Tsai; Dirk Van Gestel; Carlos Vargas; Ramesh Rengan
Journal:  Adv Radiat Oncol       Date:  2021-09-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.